NDC 71574-700

DOCUZEN

Sennosides 8.6mg And Docusate Sodium 50mg

DOCUZEN is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Village Pharma. The primary component is Sennosides; Docusate Sodium.

• Product ID: 71574-700_29102014-9b0e-4899-958d-83111f94a612
• NDC: 71574-700
• Product Type: Human Otc Drug
• Proprietary Name: DOCUZEN
• Generic Name: Sennosides 8.6mg And Docusate Sodium 50mg
• Dosage Form: Tablet
• Route of Administration: ORAL
• Marketing Start Date: 2018-11-27
• Marketing Category: OTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL
• Application Number: part334
• Labeler Name: Village Pharma
• Substance Name: SENNOSIDES; DOCUSATE SODIUM
• Active Ingredient Strength: 9 mg/1; mg/1
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 71574-700-60

60 TABLET in 1 BOTTLE, PLASTIC (71574-700-60)

• Marketing Start Date: 2018-11-27
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 71574-700-60 [71574070060]

DOCUZEN TABLET

• Marketing Category: OTC monograph not final
• Application Number: part334
• Product Type: HUMAN OTC DRUG
• Billing Unit: EA
• Marketing Start Date: 2018-11-27

Drug Details

Active Ingredients

Ingredient	Strength
SENNOSIDES	8.6 mg/1

OpenFDA Data

• SPL SET ID: 29102014-9b0e-4899-958d-83111f94a612
• Manufacturer:
  • Village Pharma
• UNII:
  • F05Q2T2JA0
  • 3FYP5M0IJX
• RxNorm Concept Unique ID - RxCUI:
  • 998740
• UPC Code:
  • 0371574700604

NDC Crossover Matching brand name "DOCUZEN" or generic name "Sennosides 8.6mg And Docusate Sodium 50mg"

NDC	Brand Name	Generic Name
71205-282	DOCUZEN	Sennosides 8.6mg and Docusate Sodium 50mg
71574-700	DOCUZEN	Sennosides 8.6mg and Docusate Sodium 50mg
66424-378	Senna Plus	Sennosides 8.6mg and Docusate Sodium 50mg
16103-378	Senna-S	Sennosides 8.6mg and Docusate Sodium 50mg
61715-149	Senna-S	Sennosides 8.6mg and Docusate Sodium 50mg
71205-970	Senna-S	Sennosides 8.6mg and Docusate Sodium 50mg
73057-378	Senna-S	Sennosides 8.6mg and Docusate Sodium 50mg